Just talked to Mr Lau.
Summary:
RMW owns IP and distribution rights, they are behind IVX with money and technology / scientists.
It is IMU written all over this scenario, a great tech is backdoor listed in a comp that was almost dead.
Next week, at the AGM, they could outline the next steps regarding atherosclerosis and infectious diseases as well as progressing the cancer pathway.
At Hudson Institute they are still doing more tests, everyone is excited about the pre-clinical results.
They will present results at conferences when further tests completed.
IMO, another, maybe smaller, IMU getting established. Time to get set and let the experts do their job.
Looking forward to sub 2c buying, if offered.
His phone number +61 409 341 613
GLTA
Add to My Watchlist
What is My Watchlist?
